Skip to content

Clinical trials

Completed Carcinoma, Renal Cell trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Completed Country / region: Norway Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20101
20112
20121
20171
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Active Biotech AB1
Agenus Inc.1
Bristol-Myers Squibb1
European Organisation for Research and Treatment of Cancer - EORTC1
Hoffmann-La Roche1
Immatics Biotechnologies GmbH1
Incyte Corporation1
Oslo University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell10
Kidney Neoplasms2
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Transitional Cell1
Neoplasm Metastasis1
Neoplasms1
Nephrolithiasis1
Pancreatic Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.